NIH-funded research R01 grant

Chronic nicotine effects on brainstem neurons in Parkinson's disease risk

Official title: Chronic nicotine effects on vulnerable brainstem neurons

Funded at Georgetown University · NIH-11365320 · Data updated 2026-11-12

A new study at Georgetown University will explore whether long-term nicotine exposure can strengthen brainstem neurons to potentially reduce Parkinson's disease risk in the future.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionGeorgetown University
NIH-funded
Lab location1 site (Washington, United States)
Project startJuly 6, 2026
Project endJune 30, 2031
Funding year2026
Award (this year)$531,306
NIH project number1R01NS142876-01A1
Project IDNIH-11365320 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to direct patient participation; this is an animal-model study.

Less likely to help

Direct patient participation is not involved in this animal-focused research.

What this research studies

Researchers will use animal models to examine how persistent exposure to nicotine changes brainstem neurons that are usually vulnerable in Parkinson’s disease. The study aims to identify lasting brain changes that may make these neurons more resilient after nicotine exposure has stopped. Findings could point to why past nicotine use is linked with lower PD risk and help guide future protective strategies. This work focuses on specific brain cells in regions like the substantia nigra and pedunculopontine nucleus. Results may inform whether similar protective mechanisms could be relevant to people at risk for PD.

Why it matters

Potential benefit: If successful, this research could lay the groundwork for strategies that bolster brain resilience against Parkinson's disease.

How similar studies have gone: Previous work shows nicotine’s protective effects in models, but lasting post-exposure protection mechanisms are not fully understood.

Where this research is happening

  • Georgetown University
    Washington, United States
    Active

Researchers

  • Principal investigator: Evans, Rebekah Coleman — Georgetown University
  • Study coordinator: Evans, Rebekah Coleman

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.